Goksoy Solak, Y. Et Al. 2023. Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. ENDOCRINE , vol.82, no.2 , 353-360.

Goksoy Solak, Y., Yegen, G., Onder, S., Tekin, S., SOYLUK SELÇUKBİRİCİK, Ö., Gul, N., ... Tanakol, R.(2023). Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. ENDOCRINE , vol.82, no.2, 353-360.

Goksoy Solak, Yağmur Et Al. "Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer," ENDOCRINE , vol.82, no.2, 353-360, 2023

Goksoy Solak, Yağmur G. Et Al. "Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer." ENDOCRINE , vol.82, no.2, pp.353-360, 2023

Goksoy Solak, Y. Et Al. (2023) . "Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer." ENDOCRINE , vol.82, no.2, pp.353-360.

@article{article, author={Yağmur GÖKSOY SOLAK Et Al. }, title={Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer}, journal={ENDOCRINE}, year=2023, pages={353-360} }